New contrast dye for brain and spine MRI
Treatments studied
Part of Brain & nervous system clinical trials.
This study tests a new contrast dye used during MRI scans of the brain or spine. It may help doctors see lesions more clearly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a known or highly suspected brain or spinal cord condition that shows up on an MRI scan
- You are scheduled for a brain or spine MRI with contrast dye and are willing to have two such scans
- You do not have moderate or severe kidney problems (eGFR under 60)
- You do not have metal implants or severe claustrophobia that prevent an MRI
- You are not pregnant, breastfeeding, or planning to conceive without birth control
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new contrast agent called mangaciclanol for MRI scans of the central nervous system (brain and spine) or body areas like the chest, belly, pelvis, and muscles. You may join if you have known or suspected tumors that need an MRI with contrast, and you're healthy enough to have two contrast MRIs within a short time.
This trial tests whether two special MRI contrast medicines—gadolinium and ferumoxytol—can better diagnose problems in the brain or central nervous system. It may help doctors identify what’s causing symptoms or abnormal brain findings.
This trial compares two contrasting dyes (gadopiclenol and gadobutrol) used during pituitary MRI scans to see which one provides clearer images. It is for adults with known or suspected pituitary lesions that disrupt the blood-brain barrier.
This trial uses a new type of MRI contrast dye (USPIO) to get clearer images of certain slow-growing brain tumors (vestibular schwannomas and low-grade gliomas). The goal is to see if this dye helps doctors better understand and treat these tumors.
This trial tests a new portable MRI machine that uses a standard contrast dye (gadolinium) to better see brain lesions like tumors or infections. It may help people who need an MRI but cannot easily get to a traditional scanner.
This trial tests new MRI (scanner) software and hardware and checks how safely people can complete the scan. You may qualify if you’re an adult who can do MRI safely and (if contrast is used) have adequate kidney function and no relevant allergy.
Hear when a new For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Central Nervous System (CNS) Lesions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.